» Articles » PMID: 22389331

Quantifying Apoprotein Synthesis in Rodents: Coupling LC-MS/MS Analyses with the Administration of Labeled Water

Abstract

Stable isotope tracer studies of apoprotein flux in rodent models present difficulties as they require working with small volumes of plasma. We demonstrate the ability to measure apoprotein flux by administering either (2)H- or (18)O-labeled water to mice and then subjecting samples to LC-MS/MS analyses; we were able to simultaneously determine the labeling of several proteolytic peptides representing multiple apoproteins. Consistent with relative differences reported in the literature regarding apoprotein flux in humans, we found that the fractional synthetic rate of apoB is greater than apoA1 in mice. In addition, the method is suitable for quantifying acute changes in protein flux: we observed a stimulation of apoB production in mice following an intravenous injection of Intralipid and a decrease in apoB production in mice treated with an inhibitor of microsomal triglyceride transfer protein. In summary, we demonstrate a high-throughput method for studying apoprotein kinetics in rodent models. Although notable differences exist between lipoprotein profiles that are observed in rodents and humans, we expect that the method reported here has merit in studies of dyslipidemia as i) rodent models can be used to probe target engagement in cases where one aims to modulate apoprotein production and ii) the approach should be adaptable to studies in humans.

Citing Articles

Measurement of lipid flux to advance translational research: evolution of classic methods to the future of precision health.

Salvador A, Shyu C, Parks E Exp Mol Med. 2022; 54(9):1348-1353.

PMID: 36075949 PMC: 9534914. DOI: 10.1038/s12276-022-00838-5.


Glucagon receptor antagonism induces increased cholesterol absorption.

Guan H, Yang X, Lu K, Wang S, Castro-Perez J, Previs S J Lipid Res. 2015; 56(11):2183-95.

PMID: 26373568 PMC: 4617405. DOI: 10.1194/jlr.M060897.


Tracer-based estimates of protein flux in cases of incomplete product renewal: evidence and implications of heterogeneity in collagen turnover.

Zhou H, Wang S, Herath K, Kasumov T, Sadygov R, Previs S Am J Physiol Endocrinol Metab. 2015; 309(2):E115-21.

PMID: 26015435 PMC: 4596733. DOI: 10.1152/ajpendo.00435.2014.


Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis.

Kasumov T, Li L, Li M, Gulshan K, Kirwan J, Liu X PLoS One. 2015; 10(5):e0126910.

PMID: 25993337 PMC: 4439060. DOI: 10.1371/journal.pone.0126910.


Quantifying protein synthesis and degradation in Arabidopsis by dynamic 13CO2 labeling and analysis of enrichment in individual amino acids in their free pools and in protein.

Ishihara H, Obata T, Sulpice R, Fernie A, Stitt M Plant Physiol. 2015; 168(1):74-93.

PMID: 25810096 PMC: 4424029. DOI: 10.1104/pp.15.00209.


References
1.
Shah V, Herath K, Previs S, Hubbard B, Roddy T . Headspace analyses of acetone: a rapid method for measuring the 2H-labeling of water. Anal Biochem. 2010; 404(2):235-7. DOI: 10.1016/j.ab.2010.05.010. View

2.
Bjorkegren J, Packard C, Hamsten A, Bedford D, Caslake M, Foster L . Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway. J Lipid Res. 1996; 37(1):76-86. View

3.
Kombu R, Zhang G, Abbas R, Mieyal J, Anderson V, Kelleher J . Dynamics of glutathione and ophthalmate traced with 2H-enriched body water in rats and humans. Am J Physiol Endocrinol Metab. 2009; 297(1):E260-9. PMC: 2711657. DOI: 10.1152/ajpendo.00080.2009. View

4.
Kay R, Gregory B, Grace P, Pleasance S . The application of ultra-performance liquid chromatography/tandem mass spectrometry to the detection and quantitation of apolipoproteins in human serum. Rapid Commun Mass Spectrom. 2007; 21(16):2585-93. DOI: 10.1002/rcm.3130. View

5.
Previs S, Fatica R, Chandramouli V, Alexander J, Brunengraber H, Landau B . Quantifying rates of protein synthesis in humans by use of 2H2O: application to patients with end-stage renal disease. Am J Physiol Endocrinol Metab. 2003; 286(4):E665-72. DOI: 10.1152/ajpendo.00271.2003. View